The Relationship of Plasma Zinc Concentration and Hepatic Encephalopathy in Patients with Cirrhosis

Document Type : Original Article(s)

Authors

1 Assistant Professor, Department of Internal Medicine, School of Medicine, Islamic Azad University, Najafabad Branch, Isfahan, Iran

2 Student of Medicine, School of Medicine, Islamic Azad University, Najafabad Branch, Isfahan, Iran

3 General Practitioner, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Zinc deficiency is prevalent in Iran. Regarding the effect of zinc element on pathogenesis of cirrhosis and hepatic encephalopathy, the present study has been designed to assess the zinc deficiency in patients with cirrhosis, with and without hepatic encephalopathy.Methods: This descriptive-analytical cross-sectional study was done in internal ward of Shariati Hospital, Isfahan, Iran, in 2011. 80 patients with cirrhosis, with any etiology, were chosen and divided in two groups of with and without hepatic encephalopathy. They were examined for plasma zinc concentration. The recorded data was analyzed via Stata11 software.Findings: 80 patients with cirrhosis with the mean (± standard deviation) age of 50.97 ± 14.51 years were evaluated. There were 44 men (55 percent) and 36 women (45 percent). The mean (± standard deviation) concentration of plasma zinc was 87.50 ± 27.03 µg/dl. The plasma zinc concentration was low in 26.25 percent. The mean (± standard deviation) concentration of plasma zinc in patients with and without hepatic encephalopathy was 75.10 ± 23.9 and 104.00 ± 23.10 µg/dl, respectively, with significant statistically difference (P < 0.05). No relationships were found between the age, gender, and serum zinc concentration (P > 0.05).Conclusion: The plasma zinc concentration was low in patients with cirrhosis, especially in those with hepatic encephalopathy; therefore, measurement of plasma zinc concentration should be considered for patients with cirrhosis, especially in those with hepatic encephalopathy to do the suitable treatment. 

Keywords

References

  1. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30(5): 890-5.
  2. Dbouk N, McGuire BM. Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Options Gastroenterol 2006; 9(6): 464-74.
  3. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35(3): 716-21.
  4. Krebs NE, Hambidge KM. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals 2001; 14(3-4): 397-412.
  5. Grungreiff K. Zinc in liver disease. J Trace Elem Exp Med 2002; 15(1): 67-78.
  6. Pincus MR, Henry JB. Clinical chemistry. In: Henry JB, editor. Clinical diagnosis and management by laboratory methods. 20th ed. Philadelphia, PA: Saunders Company; 2001. p. 159-366.
  7. Yang SS, Lai YC, Chiang TR, Chen DF, Chen DS. Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials. J Gastroenterol Hepatol 2004; 19(4): 375-9.
  8. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96(9): 2718-23.
  9. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 1984; 2(8401): 493-5.
  10. Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur J Med 1993; 2(7): 414-6.
  11. Quero Guillen JC, Carmona S, I, Garcia Montes JM, Jimenez SM, Herrerias Gutierrez JM. Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev Esp Enferm Dig 2003; 95(2): 135-34.
  12. Prasad AS, Miale A, Jr., Farid Z, Sandstead Hh, Schulert AR. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J Lab Clin Med 1963; 61: 537-49.
  13. Conn H, Lieberthal M. The hepatic coma syndromes and lactulose. Baltimore, MD: Williams and Wilkins; p. 1979.
  14. Jacobs DS, DeMott WR, Oxley DK. Laboratory test handbook. 5th ed. Hudson,OH: Lexi-Comp Inc; 2001. p. 1169.
  15. Burtis CA, Ashwood ER. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia, PA: Saunders Company; 1999. p. 1029-43.
  16. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45(3): 797-805.
  17. Child CG, Turcotte JG. The liver and portal hypertension. Philadelphia, PA: Saunders; 1964.
  18. Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci 2007; 52(7): 1595-612.
  19. Soomro AA, Devrajani BR, Shaikh K, Shah SZA, Devrajani T, Bibi I. Serum zinc level in patients with liver cirrhosis. Pak J Med Sci 2009; 25(6): 986-91.
  20. Schneider AC, Pinto RB, Froehlich PE, Hammes TO, Silveira TR. Low plasma zinc concentrations in pediatric patients with cirrhosis. J Pediatr (Rio J) 2009; 85(4): 359-64.
  21. Poo JL, Rosas-Romero R, Rodriguez F, Silencio JL, Munoz R, Bourges H, et al. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis 1995; 13(2): 136-42.
  22. Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference values for serum zinc concentration and prevalence of zinc deficiency in adult Iranian subjects. Biol Trace Elem Res 2012; 149(3): 307-14.
  23. Hassanein TI, Tofteng F, Brown RS, Jr., McGuire B, Lynch P, Mehta R, et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007; 46(6): 1853-62.
  24. Loomba V, Pawar G, Dhar KL, Setia MS. Serum zinc levels in hepatic encephalopathy. Indian J Gastroenterol 1995; 14(2): 51-3.
  25. Rahelic D, Kujundzic M, Romic Z, Brkic K, Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol 2006; 30(3): 523-8.
  26. Ramzy I, Doss W, Mokhtar S, Abdel Hafez H, Abdel Kader A, Amira El Gohary A, et al. serum zinc level as a predictor of subclinical hepatic encephalopathy in patients with liver cirrhosis. Arab J Gastroenterol 2008; 9(4): 101-5
  27. Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, et al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama 2001; 55(6): 349-55.
Journal of Isfahan Medical School
Volume 32, Issue 303 - Serial Number 303
July and August 2014
Pages 1577-1584

Files

History

  • Receive Date: 02 February 2014
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics